Tianjin Lisheng PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Tianjin Lisheng PharmaceuticalLtd has a total shareholder equity of CN¥5.0B and total debt of CN¥56.1M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are CN¥6.1B and CN¥1.1B respectively. Tianjin Lisheng PharmaceuticalLtd's EBIT is CN¥105.7M making its interest coverage ratio -1.1. It has cash and short-term investments of CN¥2.2B.
Key information
1.1%
Debt to equity ratio
CN¥56.13m
Debt
Interest coverage ratio | -1.1x |
Cash | CN¥2.15b |
Equity | CN¥5.00b |
Total liabilities | CN¥1.08b |
Total assets | CN¥6.08b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002393's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥818.7M).
Long Term Liabilities: 002393's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥260.6M).
Debt to Equity History and Analysis
Debt Level: 002393 has more cash than its total debt.
Reducing Debt: 002393's debt to equity ratio has increased from 0.7% to 1.1% over the past 5 years.
Debt Coverage: 002393's debt is well covered by operating cash flow (397.1%).
Interest Coverage: 002393 earns more interest than it pays, so coverage of interest payments is not a concern.